FDA Allows Temporary Imports Of Chemo Drugs From Chinese Facility

FDA hopes to combat a shortage of chemotherapy drugs in the United States by allowing temporary imports from a Chinese manufacturer, although the cisplatin product that will be made available has not been reviewed by FDA. Qilu Pharmaceutical will import the injectable chemotherapy drug cisplatin in 50-milligram vials, with U.S. distribution through the Canadian pharmaceutical company Apotex Corporation. Senate Majority Whip Dick Durbin (D-IL) called on FDA June 1 , the day before the measures were announced, to use all...